Next Article in Journal
Pregnancy AI: Development and Internal Validation of an Artificial Intelligence Tool to Predict Live Births in ICSI and IVF Cycles Using Clinical Features and Embryo Images
Next Article in Special Issue
Maternal Cardiovascular Emergencies During Pregnancy and the Puerperium: Current Diagnostic Approach and Management
Previous Article in Journal
Utility of the US Metabolic Syndrome Severity Calculator for Group-Level Comparison in Estonia
Previous Article in Special Issue
The Monday Effect: Weekly and Circadian Patterns in Acute Cardiovascular Emergencies Monday Effect in Cardiovascular Emergencies
 
 
Article
Peer-Review Record

Use of the Hypoxia–Age–Shock Index at Triage to Predict Mortality in Geriatric STEMI Patients Undergoing Primary PCI

Medicina 2026, 62(2), 365; https://doi.org/10.3390/medicina62020365
by Man-Ju Ting 1,†, Wan-Ju Chao 2,†, San-Fang Chou 3, Shyh-Shyong Sim 4, Chih-Jung Chang 4 and Chien-Chieh Hsieh 4,5,6,7,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Medicina 2026, 62(2), 365; https://doi.org/10.3390/medicina62020365
Submission received: 15 January 2026 / Revised: 6 February 2026 / Accepted: 10 February 2026 / Published: 12 February 2026
(This article belongs to the Special Issue Acute Cardiovascular Events: Broadening Perspectives in Acute Care)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

This single-center retrospective cohort study (2019–2023) assessed whether the Hypoxia–Age–Shock Index (HASI = ASI/SpOâ‚‚) derived from triage vital signs improves early risk stratification in STEMI patients undergoing primary PCI, with a focus on older adults (≥65 years).  The study included 711 STEMI patients (254 ≥65 years). HASI demonstrated numerically higher discrimination than SI and ASI for in-hospital mortality (AUC 0.703 in elderly; 0.743 in younger). The topic is clinically relevant: a rapid triage index using readily available parameters is important and clinically atractive. However, the manuscript needs methodological tightening and more cautious interpretation, especially given moderate AUCs and non-significant DeLong comparisons.

My comments are as follows:

  1. Definition of HASI - the authors should clarify how shock index was calculated. They also need to clarify the definition and clinical meaning of SpOâ‚‚ in HASI (on room air or with oxygen).
  2. Endpoint definition. The authors need to clarify whether post-discharge deaths are captured (for 30-day mortality) and how follow-up completeness was ensured. If only data on in-hospital mortality were available (assuming that some patients required longer hospitalisation), they should not be labeled as 30-day mortality.

  3.  Primary endpoint and modeling are not aligned (in-hospital vs 30-day). The abstract and introduction list in-hospital mortality as primary outcome, but statistical modeling focuses on 30-day mortality (Kaplan–Meier, Cox, logistic regression). The authors need to clearly define  the primary endpoint (in-hospital or 30-day). If both are important, the authors shouls present pre-specified co-primary or hierarchical endpoints and keep analyses consistent.
  4. Choice of models and covariate adjustment is insufficient. The multivariable models appear adjusted only for age group and sex, which is inadequate given that these are the two variables for which predictive value is being assessed. HASI was not tested at all. The authors should provide a pre-specified adjustment set (e.g., sex, Killip class/shock, creatinine, hemoglobin, cardiac arrest, D2B, LMCA involvement, multivessel disease) fo HASI and provide the results of the univariable and multivariable model built on the selection of variables with statistically significant association with the outcome in univariable analysis.
  5. Discrimination claims should be toned down (AUC differences not significant). The state HASI is “superior,” yet DeLong tests show no significant differences between AUCs. This should be corrected. Defining cut-off valuase for HASI would be valuable.
  6. Calibration is missing. AUC alone is incomplete. A triage tool requires both discrimination and calibration. Please add calibration metrics/plots (e.g., Hosmer–Lemeshow). 
  7. Major adverse event needs a clear definition. 

Author Response

  • Please find the point-by-point response to reviewers including tables, and figures in the attached file.

 

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Dear authors, thank you for the opportunity to review your manuscript.
This article addresses an important issue: risk stratification for adverse outcomes in patients with myocardial infarction. The relevance of the study is beyond doubt.
I have a number of comments and suggestions for improving the presentation of your study results.

Critical Comments.
1. Relevance.
Existing risk stratification tools (e.g., GRACE) have been repeatedly validated and have higher discriminatory potential than the indices you are studying. Why was it necessary to study new indices? What is wrong with the GRACE model? What do we gain by faster (approximately 30 minutes) risk stratification, while clearly losing the accuracy of our prognosis? These are key questions that require answers in the "Relevance" section.
2. Limitations of the study.
This section is missing from the manuscript. However, limitations of the study include its retrospective design, single-center nature, and the moderate discriminatory power of the predictive models you constructed, which require validation in larger, independent samples.

Minor comments.
The study would have been more comprehensive if it had included an analysis of the relationship between clinical, anamnestic, laboratory, and functional data with the HASI score and a HASI cutoff value, which predicts a higher incidence of adverse outcomes. These data are highly relevant as they can influence clinical decision making.

Author Response

  • Please find the point-by-point response to reviewers including tables, and figures in the attached file.

 

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

At this point I have no further comments

Author Response

Second minor revision

Reply to Academic Editors

Academic Editor Comments:

Dear authors, This is a very interesting and well-written paper. A few comments to consider. 1. The authors report in methods that "Notably, the SpOâ‚‚ values used for HASI calculation were the first recorded measurements obtained while patients were breathing room air upon emergency department arrival, reflecting the baseline oxygenation status without the confounding effect of supplemental oxygen therapy." In case STEMI patients arrived at the ED with an ambulance and had already received supplemental oxygen in the prehospital setting, were these patients excluded from this study? If yes, please add this in the limitations section, as you excluded patients probably at higher risk (since they used an ambulance). If no, please explain if SPO2 was measured by the pre-hospital staff.

Response to Academic Editor Comment

Thank you for this insightful comment and for the opportunity to clarify this important methodological point.

Patients who arrived at the emergency department (ED) via ambulance were not excluded from the present study. In our study design, the inclusion criteria comprised two categories of patients: (1) patients breathing room air at the time of ED arrival, and (2) patients transported by ambulance.

For patients transported by emergency medical services (EMS), peripheral oxygen saturation (SpOâ‚‚) was routinely measured by emergency medical technicians (EMTs) prior to the initiation of any supplemental oxygen therapy in the prehospital setting. This initial SpOâ‚‚ measurement, obtained while the patient was breathing room air, was used by EMTs as part of their standard clinical assessment to determine the need for oxygen administration. Importantly, for the purposes of this study, we deliberately selected this first recorded prehospital SpOâ‚‚ value before oxygen supplementation for HASI calculation.

Upon arrival at the ED, although some patients were initially assessed while receiving supplemental oxygen, triage nurses routinely removed oxygen devices and reassessed SpOâ‚‚ as part of standard triage procedures. However, to ensure consistency and to avoid the confounding effects of oxygen therapy, we did not use these post-intervention measurements. Instead, we consistently used the earliest available SpOâ‚‚ value obtained while patients were breathing room air, including those measured in the prehospital setting prior to oxygen administration.

Therefore, patients who received supplemental oxygen during ambulance transport were not excluded, and their baseline oxygenation status was appropriately captured using pre-oxygen SpOâ‚‚ measurements recorded by prehospital staff. We have revised the Methods section to explicitly clarify this point and to improve transparency regarding SpOâ‚‚ data acquisition.

---------------------------------------------------------------------------------------------------------------

We have revised 2.3. Definition of Physiologic Indices as follows:

Three hemodynamic indices were calculated at triage to quantify circulatory and oxygenation status. The SI was defined as the ratio of heart rate (beats per minute) to systolic blood pressure (mmHg). The ASI was calculated by multiplying the patient’s chronological age by the SI, thereby incorporating the effect of age into the assessment of hemodynamic instability. The HASI was computed by dividing the ASI by SpOâ‚‚, integrating oxygenation into the age-adjusted shock model [6].

Notably, the SpOâ‚‚ values used for HASI calculation were defined as the earliest available measurements obtained while patients were breathing room air, including those recorded in the prehospital setting by emergency medical technicians prior to the initiation of supplemental oxygen therapy for patients transported by ambulance. For patients arriving at the emergency department without prehospital oxygen supplementation, the first SpOâ‚‚ measurement obtained at ED triage while breathing room air was used. Post-intervention SpOâ‚‚ measurements obtained after oxygen administration were not used for analysis to avoid confounding effects of supplemental oxygen therapy.

All indices were derived from the first recorded vital signs reflecting baseline physiological status prior to the administration of pharmacologic therapy or performance of PCI. This pragmatic marker at initial assessment captures the early physiological state and potential pulmonary congestion or systemic hypoperfusion associated with acute myocardial infarction.

Author's Reply to the Review Report (Reviewer 1)

Comments and Suggestions for Authors

At this point I have no further comments

Response to Reviewer

We sincerely thank the reviewer for their careful reassessment of our revised manuscript. We greatly appreciate the reviewer’s time and effort and are pleased to learn that there are no further comments or concerns at this stage.

Author's Reply to the Review Report (Reviewer 2)

Comments and Suggestions for Authors

The authors responded to all questions and comments and made significant edits to the text of the manuscript.

Response to Reviewer

We sincerely thank the reviewer for the careful evaluation of our revised manuscript and for the positive assessment. We appreciate the reviewer’s recognition of our responses and the substantial revisions made to improve the clarity and quality of the manuscript.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The authors responded to all questions and comments and made significant edits to the text of the manuscript.

Author Response

Second minor revision

Reply to Academic Editors

Academic Editor Comments:

Dear authors, This is a very interesting and well-written paper. A few comments to consider. 1. The authors report in methods that "Notably, the SpOâ‚‚ values used for HASI calculation were the first recorded measurements obtained while patients were breathing room air upon emergency department arrival, reflecting the baseline oxygenation status without the confounding effect of supplemental oxygen therapy." In case STEMI patients arrived at the ED with an ambulance and had already received supplemental oxygen in the prehospital setting, were these patients excluded from this study? If yes, please add this in the limitations section, as you excluded patients probably at higher risk (since they used an ambulance). If no, please explain if SPO2 was measured by the pre-hospital staff.

Response to Academic Editor Comment

Thank you for this insightful comment and for the opportunity to clarify this important methodological point.

Patients who arrived at the emergency department (ED) via ambulance were not excluded from the present study. In our study design, the inclusion criteria comprised two categories of patients: (1) patients breathing room air at the time of ED arrival, and (2) patients transported by ambulance.

For patients transported by emergency medical services (EMS), peripheral oxygen saturation (SpOâ‚‚) was routinely measured by emergency medical technicians (EMTs) prior to the initiation of any supplemental oxygen therapy in the prehospital setting. This initial SpOâ‚‚ measurement, obtained while the patient was breathing room air, was used by EMTs as part of their standard clinical assessment to determine the need for oxygen administration. Importantly, for the purposes of this study, we deliberately selected this first recorded prehospital SpOâ‚‚ value before oxygen supplementation for HASI calculation.

Upon arrival at the ED, although some patients were initially assessed while receiving supplemental oxygen, triage nurses routinely removed oxygen devices and reassessed SpOâ‚‚ as part of standard triage procedures. However, to ensure consistency and to avoid the confounding effects of oxygen therapy, we did not use these post-intervention measurements. Instead, we consistently used the earliest available SpOâ‚‚ value obtained while patients were breathing room air, including those measured in the prehospital setting prior to oxygen administration.

Therefore, patients who received supplemental oxygen during ambulance transport were not excluded, and their baseline oxygenation status was appropriately captured using pre-oxygen SpOâ‚‚ measurements recorded by prehospital staff. We have revised the Methods section to explicitly clarify this point and to improve transparency regarding SpOâ‚‚ data acquisition.

---------------------------------------------------------------------------------------------------------------

We have revised 2.3. Definition of Physiologic Indices as follows:

Three hemodynamic indices were calculated at triage to quantify circulatory and oxygenation status. The SI was defined as the ratio of heart rate (beats per minute) to systolic blood pressure (mmHg). The ASI was calculated by multiplying the patient’s chronological age by the SI, thereby incorporating the effect of age into the assessment of hemodynamic instability. The HASI was computed by dividing the ASI by SpOâ‚‚, integrating oxygenation into the age-adjusted shock model [6].

Notably, the SpOâ‚‚ values used for HASI calculation were defined as the earliest available measurements obtained while patients were breathing room air, including those recorded in the prehospital setting by emergency medical technicians prior to the initiation of supplemental oxygen therapy for patients transported by ambulance. For patients arriving at the emergency department without prehospital oxygen supplementation, the first SpOâ‚‚ measurement obtained at ED triage while breathing room air was used. Post-intervention SpOâ‚‚ measurements obtained after oxygen administration were not used for analysis to avoid confounding effects of supplemental oxygen therapy.

All indices were derived from the first recorded vital signs reflecting baseline physiological status prior to the administration of pharmacologic therapy or performance of PCI. This pragmatic marker at initial assessment captures the early physiological state and potential pulmonary congestion or systemic hypoperfusion associated with acute myocardial infarction.

Author's Reply to the Review Report (Reviewer 1)

Comments and Suggestions for Authors

At this point I have no further comments

Response to Reviewer

We sincerely thank the reviewer for their careful reassessment of our revised manuscript. We greatly appreciate the reviewer’s time and effort and are pleased to learn that there are no further comments or concerns at this stage.

Author's Reply to the Review Report (Reviewer 2)

Comments and Suggestions for Authors

The authors responded to all questions and comments and made significant edits to the text of the manuscript.

Response to Reviewer

We sincerely thank the reviewer for the careful evaluation of our revised manuscript and for the positive assessment. We appreciate the reviewer’s recognition of our responses and the substantial revisions made to improve the clarity and quality of the manuscript.

Author Response File: Author Response.pdf

Back to TopTop